Clostridium niameyense sp. nov. strain MT5 is the type strain of C. niameyense sp. nov., a new species within the genus Clostridia. C. niameyense is a Gram-positive, anaerobic bacillus. The strain MT5 (= CSUR P1468 = DSMZ 100441), whose genome is described here, was isolated from a faecal sample collected from a patient with anorexia and marasmus living in Nigeria. The genome is 2 542 841 bp long with 27.44% G + C content and consists of six scaffolds.
Introduction
Clostridium niameyense strain MT5 (= CSUR P1468 = DSMZ 100441) is the type strain of C. niameyense sp. nov. This bacterium is a Gram-positive, anaerobic, motile bacterium that was isolated from the stool of an anorexic patient with marasmus living in Nigeria as part of a culturomics study aiming at cultivating all species individually within human faeces [1, 2] .
The usual parameters used to delineate a bacterial species include 16S rDNA sequence identity and phylogeny [3] , genomic G + C content diversity and DNA-DNA hybridization [3] . Recently a new approach has been proposed, taxonogenomics, which includes genomic data in a polyphasic taxonomy to describe new bacterial species [4] . This strategy is based on a combination of genomic and phenotypic characteristics, including matrix-assisted desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) as well as spectrum and genomic analyses [5] .
Clostridium is a genus of Gram-positive bacteria which includes several significant human pathogens and consists of obligate anaerobic bacteria [6] . These bacteria are the cause of some human diseases such as botulism (C. botulinum), tetanus (C. tetani), pseudomembranous colitis (C. difficile) and food poisoning-gas gangrene (C. perfringens) [7] . The pathogenic clostridial species have evolved several mechanisms to survive inside and outside a number of hosts, as evidenced by various diseases often linked to their protein toxins and spores [8] .
Here we present a summary classification and set of features for C. niameyense sp. nov. strain MT5 together with the description of the complete genome sequence and annotation. These characteristics support the circumscription of the species C. niameyense.
Phenotypic and biochemical characterization
Clostridium niameyense sp. nov. strain MT5 was isolated from a faecal sample collected from an anorexic patient with marasmus living in Nigeria. The faecal specimen was preserved at −80°C after collection and sent to Marseille. The MT5 strain was cultivated on 5% sheep's blood-enriched Columbia agar (bio-Mérieux, Marcy l'Etoile, France) after 5 days' preincubation in a blood culture bottle with rumen fluid.
For the growth of C. niameyense, we tested different temperatures (25, 30, 37°C). However, optimal growth occurred at 37°C, 24 hours after inoculation. Colonies were opaque with a smooth aspect, irregular and 1 mm in diameter on bloodenriched Columbia agar. Growth was observed only under anaerobic conditions, and no growth occurred under aerobic or microaerophilic conditions. Gram staining revealed a Grampositive nonsporulating bacillus; the motility test was positive ( Fig. 1) .
The obtained colonies were identified using a Microflex spectrometer (Bruker Daltonics, Bremen, Germany). MALDI-TOF MS identification, measurement and analysis were performed as previously described [1] . No significant MALDI-TOF MS score was obtained for strain MT5 against the Bruker database, suggesting that our isolate was not a member of a known species. We added the spectrum from strain MT5 to our database ( Fig. 2 ).
Biochemical features of the strains were determined using API50-CHL and the API ZYM (bioMérieux). Oxydase (Becton Dickinson, Pont-de-Claix, France) and catalase assays (bio-Mérieux) were performed separately. API ZYM presented positive reactions for α-glucosidase (maltase) and β-glucosidase (cellulase). The differential phenotypic characteristics with other Clostridium species are summarized in Table 1 .
Antibiotic susceptibility of our isolate was assessed using the disc diffusion method on Muller-Hinton agar plates supplemented with 5% blood (bioMérieux) using the standard disc diffusion procedure as recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http:// www.eucast.org/). C. niameyense was likely resistant to penicillin (14 mm), amoxicillin (13 mm), trimethoprim/sulfamethoxazole (6 mm), colistin (6 mm) and metronidazole (6 mm) but susceptible to vancomycin (22 mm), ertapenem (20 mm), fosfomycin (27 mm), teicoplanin (19 mm), oxacillin (22 mm), cefotaxime (20 mm), rifampicin (25 mm), gentamycin (27 mm), doxycycline (25 mm), pristinamycin (22 mm), erythromycin (26 mm), lincomycin (27 mm), imipenem (22 mm), tazocillin (24 mm), ofloxacin (25 mm), meropenem (20 mm) and ciprofloxacin (19 mm).
16S rRNA gene sequencing and phylogenetic analyses
The organism was selected for sequencing on the basis of its phylogenetic position and 16S rRNA similarity to members of the genus Clostridium [9] and is part of a study of the human digestive flora aiming to isolate all bacterial species in human faeces [1] . A phylogenetic tree was constructed using the maximum-likelihood method in the MEGA6 software package (https://www.megasoftware.net/). Phylogenetic analysis of the complete sequence of the 16S rRNA gene of C. niameyense strain MT5 (= CSUR P1468 = DSMZ 100441) exhibited a 98.3% nucleotide sequence similarity with Clostridium botulinum A (L37585). This value was lower than the 98.7% 16S rRNA gene sequence threshold recommended by Stackebrandt and Ebers [10] to delineate a new species without carrying out DNA-DNA hybridization ( Fig. 3 ).
Genome properties
The genome is 2 542 841 bp long with 27.44% G+C content ( Table 2 ). It is composed of six scaffolds (composed of seven contigs). Of the 2489 predicted genes, 2410 were proteincoding genes and 79 were RNAs (five genes are 5S rRNA, one gene is 16S rRNA, two genes are 23S rRNA and 71 genes are tRNA genes). A total of 1790 genes (74.27%) were assigned a putative function by Clusters of Orthologous Groups database (COGs) or by NR BLAST. Fifty-nine genes were identified as ORFans (2.45%). The remaining genes were annotated as hypothetical proteins (401 genes, >16.64%). The properties of the genome are summarized in Table 2 . A genomic comparison of C. niameyense with seven other Clostridium species is provided in Table 3 . The distribution of genes into COGs functional categories is presented in Table 4 (Fig. 4) . The genome was assembled and annotated by Xegen (http://www.xegen.fr/).
Genome annotation
The ARG-ANNOT database for acquired antibiotic resistance genes (ARGs) was used for a BLAST search using the Bio-Edit interface. The assembled sequences were searched against the ARG database under moderately stringent conditions (E value of 10 −5 ) for the in silico ARG prediction [11] . The results obtained by ARG-ANNOT demonstrated that there are no known antibiotic-resistance genes in the genome of C. niameyense strain MT5. These sequences were submitted to Rapid Annotation Using Subsystem Technology (RAST) [12] . An exhaustive search of the bacteriocin database available in our laboratories (Bacteriocins of the URMITE, BUR; http://drissifatima.wix.com/ bacteriocins) was performed by collecting all currently available sequences from the databases and from the National Center for Biotechnology Information. Protein sequences from this database allowed putative bacteriocins from human gut microbiota to be identified using BLASTp methodology [13] .
The analysis of the resistome did not identify antibiotic resistance genes, and the absence of bacteriocin was confirmed.
Analysis of the presence of polyketide synthases and nonribosomal peptide synthetases was performed by discriminating the genes with large sizes using a database realized in our laboratory; predicted proteins were compared against the nonredundant GenBank database using BLASTp and finally examined using antiSMASH [14] .
Analysis revealed five clusters of clusters of differentiation (CDs) (11 642 bp) predicted to code for enzymes involved in the nonribosomal synthesis of peptides ( Fig. 5) , which in turn were predicted to catalyze the synthesis of a siderophore (Fig. 5 ), which could be used under iron-deficient growth conditions. This mechanism is already known in Clostridium spp., particularly in in C. kluyveri DSM555. The alignment of nonribosomal synthesis in C. kluyveri DSM555 (WP_012101903.1) and C. niameyense MT5 (WP_050607297.1) showed a 31% similarity with 99% coverage.
Description of Clostridium niameyense sp. nov. strain MT5
Clostridium niameyense sp. nov. strain MT5 is the type strain of C. niameyense sp. nov., a new species within the genus Clostridia. The strain MT5 (= CSUR P1468 = DSMZ 100441), whose genome is described here, was isolated from a faecal sample collected from an anorexic patient with marasmus living in Nigeria. Optimal growth occurred at 37°C, 24 hours after inoculation. The colonies were 0.1 to 0.3 mm in diameter on blood-enriched agar. C. niameyense is a Gram-positive, obligate anaerobic bacterium with a mean diameter of 1.3 μm.
C. niameyense has positive reactions for glycerol, erythritol, D-glucose, D-fructose, D-mannitol, D-saccharose, D-trehalose Dmaltose, D-melezitose, amidone D-turanose and potassium 5cétogluconate. Also, API ZYM presented positive reactions for α-glucosidase (maltase) and 17-β-glucosidase (cellulase).
C. niameyense is resistant to penicillin (14 mm), amoxicillin (13 mm), trimethoprim/sulfamethoxazole (6 mm), colistin (6 mm) and metronidazole (6 mm) but susceptible for another antibiotic.
The G+C content of the genome is 27.44%. The 16S rDNA and genome sequences are deposited in GenBank under accession numbers LN827532 and CVPI00000000, respectively. The type strain is MT5 (= CSUR P1468 = DSMZ 100441).
